within Pharmacolibrary.Drugs.ATC.L;

model L01EA01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.98,
    Cl             = 0.19333333333333333,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.174,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 60
  );

  annotation(Documentation(
    info ="<html><body><p>Imatinib is a tyrosine kinase inhibitor used as standard of care for chronic myeloid leukemia and gastrointestinal stromal tumors.</p><h4>Pharmacokinetics</h4><p>Alternative pharmacokinetic model in healthy volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Peng, B, et al., &amp; Schran, H (2005). Clinical pharmacokinetics of imatinib. <i>Clinical pharmacokinetics</i> 44(9) 879–894. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544090-00001&quot;>10.2165/00003088-200544090-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16122278/&quot;>https://pubmed.ncbi.nlm.nih.gov/16122278</a></p></li><li><p>Mueller-Schoell, A, et al., &amp; Kloft, C (2021). Therapeutic drug monitoring of oral targeted antineoplastic drugs. <i>European journal of clinical pharmacology</i> 77(4) 441–464. DOI:<a href=&quot;https://doi.org/10.1007/s00228-020-03014-8&quot;>10.1007/s00228-020-03014-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33165648/&quot;>https://pubmed.ncbi.nlm.nih.gov/33165648</a></p></li><li><p>Lyseng-Williamson, K, &amp; Jarvis, B (2001). Imatinib. <i>Drugs</i> 61(12) 1765–1776. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161120-00007&quot;>10.2165/00003495-200161120-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11693465/&quot;>https://pubmed.ncbi.nlm.nih.gov/11693465</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01EA01_1;
